InsiderClue
← All stocks

ARVINAS, INC.

ARVN Net selling
CIK 0001655759 #2976 in the set updated 19 Sep 2026
Bought (120 mo)
$69.62M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$161.24M
$66.04K on a plan · $43.80M straight out of an exercise
Sold at will
$117.37M
118 of 200 sales
Net
−$91.62M
−$47.76M against sales at will

By person

28 insiders · 240 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
SHANNON TIMOTHY M
Director
$372.83K (5)
$34.51M (25)
−$34.14M
11,211,782
17.15%
$91.48M
+70.0%
5AM VENTURES III, L.P. entity
10% owner
—
$26.56M (8)
−$26.56M
1,002
0.0015%
$8.18K
—
Houston John G
Director
$480.00K (1)
$17.74M (26) scheduled
−$17.26M
1,122,183
1.72%
$9.16M
+51.1%
RA CAPITAL MANAGEMENT, L.P. entity
Former 10% Owner
$16.00M (1)
—
+$16.00M
3,138,412
4.80%
$25.61M
—
Ratcliffe Liam
Director
$40.96M (4)
$51.37M (39)
−$10.41M
1,008,543
1.54%
$8.23M
—
Cassidy Sean A
Chief Financial Officer
$25.60K (1)
$9.32M (26) scheduled
−$9.30M
181,916
0.2782%
$1.48M
+8.4%
Taylor Ian
President, R&D
$14.66K (1)
$7.71M (27) scheduled
−$7.69M
159,121
0.2434%
$1.30M
+88.3%
Peck Ronald
Chief Medical Officer
—
$5.05M (9) scheduled
−$5.05M
67,516
0.1033%
$550.86K
—
Flynn James E
10% owner
$5.00M (3)
—
+$5.00M
1,233,734
1.89%
$10.07M
—
Loven Jakob
Director
$5.00M (1)
—
+$5.00M
1,694,351
2.59%
$13.82M
—
Margus Bradley Albert
Director
$640.00K (1)
$5.02M (5)
−$4.38M
61,463
0.0940%
$501.48K
+3.4%
Morrison Briggs
Director
$590.53K (3)
$2.77M (7) scheduled
−$2.18M
111,548
0.1706%
$910.12K
+312.8%
Kennedy Edward Moore Jr.
Director
$535.91K (2)
—
+$535.91K
54,957
0.0840%
$448.39K
—
Berkowitz Noah
Chief Medical Officer
—
$323.78K (4)
−$323.78K
191,395
0.2927%
$1.56M
—
Cacace Angela M
Chief Scientific Officer
—
$303.60K (8)
−$303.60K
180,390
0.2759%
$1.47M
+375.6%
Saik Andrew
Chief Financial Officer
—
$261.59K (4)
−$261.59K
187,432
0.2867%
$1.53M
—
Teel Randy
President and CEO
—
$226.48K (5)
−$226.48K
285,009
0.4359%
$2.33M
+96.6%
Loomis David K
VP, Chief Accounting Officer
—
$77.53K (7)
−$77.53K
40,193
0.0615%
$327.93K
+622.8%
Canaan IX L.P.
10% owner
—
—
—
3,589,554
5.49%
$29.29M
—
ELM STREET VENTURES L P entity
Former 10% owner
—
—
—
767,623
1.17%
$6.26M
—
Norwalk Leslie V
Director
—
—
—
41,572
0.0636%
$339.19K
—
Cunningham Everett
Director
—
—
—
41,572
0.0636%
$339.19K
—
Smaldone Alsup Laurie
Director
—
—
—
41,572
0.0636%
$339.19K
—
Bain Linda
Director
—
—
—
41,572
0.0636%
$339.19K
—
AGARWAL SUNIL
Director
—
—
—
30,166
0.0461%
$246.12K
—
YOUNG JOHN D
Director
—
—
—
26,045
0.0398%
$212.50K
—
DIXON WENDY L
Director
—
—
—
9,121
0.0139%
$74.42K
+82.4%
PARMAR KUSH
Director
—
—
—
1,775
0.0027%
$14.48K
—

Individual transactions

80
Insider
Date
Role
Action
Shares
Price
Amount
Peck Ronald
11 Aug 2023
Chief Medical Officer
Sold after exercise
1,324
$24.39
$32.29K
Cassidy Sean A
1 Mar 2023
Chief Financial Officer
Sold after exercise
1,745
$29.53
$51.53K
Houston John G
1 Mar 2023
President and CEO
Sold after exercise
5,878
$29.53
$173.58K
Taylor Ian
1 Mar 2023
Chief Scientific Officer
Sold after exercise
1,051
$29.53
$31.04K
Peck Ronald
12 Aug 2022
Chief Medical Officer
Sold after exercise
1,258
$68.99
$86.79K
Morrison Briggs
14 Apr 2022
Director
Sold after exercise
10,754
$67.03
$720.89K
Morrison Briggs
14 Apr 2022
Director
Sold after exercise
7,104
$66.07
$469.36K
Morrison Briggs
14 Apr 2022
Director
Sold after exercise
3,102
$65.24
$202.37K
Cassidy Sean A
11 Mar 2022
Chief Financial Officer
Sold after exercise
15,000
$70.00
$1.05M
Houston John G
4 Mar 2022
President and CEO
Sold after exercise
6,024
$63.94
$385.17K
Cassidy Sean A
4 Mar 2022
Chief Financial Officer
Sold after exercise
1,593
$63.94
$101.86K
Taylor Ian
4 Mar 2022
Chief Scientific Officer
Sold after exercise
869
$63.94
$55.56K
Taylor Ian
15 Feb 2022
Chief Scientific Officer
Sold after exercise
100
$76.58
$7.66K
Taylor Ian
15 Feb 2022
Chief Scientific Officer
Sold after exercise
300
$75.80
$22.74K
Taylor Ian
15 Feb 2022
Chief Scientific Officer
Sold after exercise
3,841
$74.64
$286.69K
Taylor Ian
15 Feb 2022
Chief Scientific Officer
Sold after exercise
4,126
$73.68
$304.00K
Taylor Ian
15 Feb 2022
Chief Scientific Officer
Sold after exercise
5,766
$72.55
$418.32K
Taylor Ian
15 Feb 2022
Chief Scientific Officer
Sold after exercise
5,867
$71.74
$420.90K
Morrison Briggs
14 Jan 2022
Director
Sold after exercise
2,108
$67.69
$142.70K
Morrison Briggs
14 Jan 2022
Director
Sold after exercise
5,100
$67.28
$343.14K
Morrison Briggs
14 Jan 2022
Director
Sold after exercise
3,833
$65.24
$250.07K
Morrison Briggs
14 Jan 2022
Director
Sold after exercise
9,919
$64.33
$638.11K
Peck Ronald
30 Dec 2021
Chief Medical Officer
Sold after exercise
8,629
$80.96
$698.60K
Peck Ronald
30 Dec 2021
Chief Medical Officer
Sold after exercise
11,371
$80.35
$913.66K
Cassidy Sean A
17 Dec 2021
Chief Financial Officer
Sold after exercise
15,000
$70.00
$1.05M
Taylor Ian
15 Nov 2021
Chief Scientific Officer
Sold after exercise
6,484
$84.95
$550.84K
Taylor Ian
15 Nov 2021
Chief Scientific Officer
Sold after exercise
6,660
$84.14
$560.39K
Taylor Ian
15 Nov 2021
Chief Scientific Officer
Sold after exercise
6,856
$83.07
$569.51K
Ratcliffe Liam
5 Nov 2021
Director
Sold after exercise indirect
2,747
$89.86
$246.85K
Ratcliffe Liam
5 Nov 2021
Director
Sold after exercise indirect
8,676
$91.09
$790.30K
Ratcliffe Liam
5 Nov 2021
Director
Sold after exercise indirect
15,327
$91.81
$1.41M
Ratcliffe Liam
5 Nov 2021
Director
Sold after exercise indirect
1,825
$93.03
$169.79K
Ratcliffe Liam
5 Nov 2021
Director
Sold after exercise indirect
4,519
$94.08
$425.14K
Ratcliffe Liam
5 Nov 2021
Director
Sold after exercise
484
$89.65
$43.39K
Ratcliffe Liam
5 Nov 2021
Director
Sold after exercise
795
$90.29
$71.78K
Ratcliffe Liam
5 Nov 2021
Director
Sold after exercise
5,221
$91.59
$478.19K
Ratcliffe Liam
5 Nov 2021
Director
Sold after exercise
4,940
$90.75
$448.31K
Ratcliffe Liam
5 Nov 2021
Director
Sold after exercise
7,060
$91.50
$645.99K
Ratcliffe Liam
5 Nov 2021
Director
Sold after exercise
6,423
$91.50
$587.70K
Houston John G
1 Nov 2021
President and CEO
Sold after exercise
15,569
$88.86
$1.38M
Houston John G
1 Nov 2021
President and CEO
Sold after exercise
15,918
$87.98
$1.40M
Houston John G
1 Nov 2021
President and CEO
Sold after exercise
8,513
$87.13
$741.75K
Taylor Ian
16 Aug 2021
Chief Scientific Officer
Sold after exercise
301
$88.28
$26.57K
Taylor Ian
16 Aug 2021
Chief Scientific Officer
Sold after exercise
10,462
$87.67
$917.20K
Taylor Ian
16 Aug 2021
Chief Scientific Officer
Sold after exercise
9,237
$86.84
$802.14K
Peck Ronald
12 Aug 2021
Chief Medical Officer
Sold after exercise
1,363
$90.54
$123.40K
Houston John G
2 Aug 2021
President and CEO
Sold after exercise
2,746
$100.66
$276.41K
Houston John G
2 Aug 2021
President and CEO
Sold after exercise
3,441
$99.96
$343.96K
Houston John G
2 Aug 2021
President and CEO
Sold after exercise
7,600
$98.86
$751.34K
Houston John G
2 Aug 2021
President and CEO
Sold after exercise
6,992
$97.66
$682.84K
Houston John G
2 Aug 2021
President and CEO
Sold after exercise
25,143
$96.96
$2.44M
Cassidy Sean A
28 Jul 2021
Chief Financial Officer
Sold after exercise
17,242
$100.00
$1.72M
Peck Ronald
30 Jun 2021
Chief Medical Officer
Sold after exercise
20,000
$76.69
$1.53M
Houston John G
10 Jun 2021
President and CEO
Sold after exercise
14,487
$82.46
$1.19M
Houston John G
10 Jun 2021
President and CEO
Sold after exercise
11,784
$81.75
$963.37K
Houston John G
10 Jun 2021
President and CEO
Sold after exercise
17,615
$80.52
$1.42M
Houston John G
9 Jun 2021
President and CEO
Sold after exercise
700
$80.15
$56.10K
Taylor Ian
5 Apr 2021
Chief Scientific Officer
Sold after exercise
4,450
$67.56
$300.64K
Taylor Ian
5 Apr 2021
Chief Scientific Officer
Sold after exercise
16,450
$66.80
$1.10M
Taylor Ian
5 Apr 2021
Chief Scientific Officer
Sold after exercise
4,100
$66.01
$270.64K
Houston John G
2 Mar 2021
President and CEO
Sold after exercise
8,115
$77.45
$628.50K
Cassidy Sean A
2 Mar 2021
Chief Financial Officer
Sold after exercise
2,221
$77.45
$172.02K
Taylor Ian
2 Mar 2021
Chief Scientific Officer
Sold after exercise
894
$77.45
$69.24K
Peck Ronald
16 Feb 2021
Chief Medical Officer
Sold after exercise
20,000
$77.35
$1.55M
Cassidy Sean A
16 Feb 2021
Chief Financial Officer
Sold after exercise
30
$80.43
$2.41K
Cassidy Sean A
16 Feb 2021
Chief Financial Officer
Sold after exercise
1,161
$79.42
$92.21K
Cassidy Sean A
16 Feb 2021
Chief Financial Officer
Sold after exercise
6,160
$78.65
$484.46K
Cassidy Sean A
16 Feb 2021
Chief Financial Officer
Sold after exercise
2,793
$77.62
$216.79K
Cassidy Sean A
16 Feb 2021
Chief Financial Officer
Sold after exercise
396
$80.28
$31.79K
Cassidy Sean A
16 Feb 2021
Chief Financial Officer
Sold after exercise
3,958
$79.32
$313.93K
Cassidy Sean A
16 Feb 2021
Chief Financial Officer
Sold after exercise
19,303
$78.61
$1.52M
Cassidy Sean A
16 Feb 2021
Chief Financial Officer
Sold after exercise
8,158
$77.60
$633.04K
Houston John G
16 Feb 2021
President and CEO
Sold after exercise
600
$80.25
$48.15K
Houston John G
16 Feb 2021
President and CEO
Sold after exercise
13,223
$79.72
$1.05M
Houston John G
16 Feb 2021
President and CEO
Sold after exercise
21,249
$78.66
$1.67M
Houston John G
16 Feb 2021
President and CEO
Sold after exercise
8,928
$77.62
$692.98K
Peck Ronald
14 Aug 2020
Chief Medical Officer
Sold after exercise
1,256
$27.46
$34.49K
Cassidy Sean A
19 Mar 2020
Chief Financial Officer
Sold after exercise
1,514
$37.61
$56.94K
Taylor Ian
19 Mar 2020
Chief Scientific Officer
Sold after exercise
826
$37.61
$31.07K
Houston John G
19 Mar 2020
President and CEO
Sold after exercise
5,405
$37.61
$203.28K
Show all 240 transactions →

What was left out

Form 4 filings counted 243
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 80
Sales at will 118
Transactions with no price 0
Shares from compensation/vesting 25,802,990
Sales filed before the plan box existed 81
History held since 28 Sep 2018